Patents by Inventor Adrienne E. Dubin

Adrienne E. Dubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human 5-HT3-C protein
    Patent number: 7109296
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: September 19, 2006
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler
  • DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
    Publication number: 20020137138
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Application
    Filed: September 12, 2001
    Publication date: September 26, 2002
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler
  • DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
    Patent number: 6365370
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: April 2, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler
  • DNA encoding human alpha1G-C T-Type calcium channel
    Patent number: 6358706
    Abstract: A DNA molecule encoding a novel isoform of the human T-type low voltage activated calcium channel (alpha1G-c) has been cloned and characterized. The biological and structural properties of this protein is disclosed, as is the amino acid and nucleotide sequence.
    Type: Grant
    Filed: October 26, 1999
    Date of Patent: March 19, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne E. Dubin, Jose E. Galindo, Jayashree Pyati, Jessica Y. Zhu, Mark G. Erlander